ADO 4.55% 2.3¢ anteotech ltd

ADO Long tem, page-5

  1. 5,184 Posts.
    lightbulb Created with Sketch. 1681
    European air travel nearing pre-pandemic levels now.
    The European countries live with the virus like they do with the flu.
    Numbers of flue fatalities are expected to outpace those of COVID in the coming Winter due to falling immunity in the community, nobody had the flu lately.

    The world is concentrating on increasingly effective vaccines, global coordination of efforts to immunise, vaccine passports and an ongoing mask and social distancing feature in our societies.
    Testing regimes become secondary in Europe now as the Florida outbreak shows that unvaccinated pockets are suffering high infection and fatality rates, the vaccinated areas are fine with milder symptoms.

    The antiviral treatment opportunities will allow a pill to be administered against COVID.
    As soon as one case appears in a company, the entire staff will take a pill.
    Such developments are in place in the US and the FDA is about to clear those last hurdles in the coming months.
    Australia is way behind with lockdowns and zero COVID policies which are unsustainable and cost a fortune.

    Our vulnerable populations will have an additional virus to deal with, causing fatalities every year as the flue does.
    The UK has 20000 flu fatatlilies a year, nobody locked the country for that in the past.
    Those numbers were accepted as the norm.
    COVID will be no different.

    The world will focus on accelerated vaccine rollout and Australia will have to introduce compulsive testing for unvaccined in order to get into anything from stadiums to bars.
    That caused many in Europe who were hesitant to get vaccinated as they had to pay for those tests and deal with the inconvenience of constant testing to finally get vaccinated.



    Anteo will have sales, much more humble in numbers than many here expected, but has achieved market entry.
    COVID enabled that and that is a major success.
    Growth from here on could be gradual and slow, something holders will have to get used to.

    Once our pipeline grows with more tests available, we can secure a market niche in hospitals and doctor surgeries which would be willing to install our readers.
    Mass functions are out of the picture now as vaccine passports take over.

    all IMO
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.